New cancer clinical trial: Neoadjuvant Tamoxifen, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer

Published on: June 29, 2018 at 12:00PM
Condition:   Breast Cancer
Interventions:   Drug: Avelumab;   Drug: Tamoxifen;   Drug: Palbociclib
Sponsors:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;   Pfizer
Not yet recruiting
https://ift.tt/2KvFdnn